Anti-CCP antibodies, rheumatoid factors and anti-keratin antibodies: Clinical value in established rheumatoid arthritis

Tunisie Medicale

Volumn 89, Issue 3, 2011, Pages 231-235

  Amri, Mohamed ^a   Sfar, Imen ^a   Skhiri, Hajer ^b   Dhaouadi, Tarek ^a   Bel Hadj, Noura ^a   Abdelmoula, Leila ^a   Zouari, Rafik ^a   Ayed, Khaled ^a   Gorgi, Yousr ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Anti CCP; Anti keratin antibodies; Rheumatoid arthritis; Rheumatoid factors

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; KERATIN ANTIBODY; RHEUMATOID FACTOR;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SEROLOGY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KERATINS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 79952729303     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358: 903-11. (Pubitemid 32900579)
2. NG K, Austin P, Ameratunga R, McQueen F. Role of anticyclic citrullinated peptide 2 assay in long-standing rheumatoid arthritis. APLAR Journal of Rheumatology 2006; 9: 211-5. (Pubitemid 44473289)
3. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
4. Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1079-84. (Pubitemid 39120358)
5. Meyer O, Fabregas D, Cyna L, Ryckewaert A. Anti-keratin antibodies. A marker of progressive rheumatoid arthritis. Rev Rhum Mal Osteoartic 1986; 53: 601-5.
6. Greiner A, Plischke H, Kellner H, Gruber R. Association of anticyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad Sci 2005; 1050: 295-303. (Pubitemid 41129447)
7. Bas S, Genevay S, Meyer O, Gabay C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 2003; 42: 677-80.
8. Prevoo ML, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
9. Zendman AJ, Van Venrooij WJ, Pruijn GJ. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 2006; 45: 20-5. Review.
10. Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.QJM 2007; 100: 193-201.
11. Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis. BMC Musculoskelet Disord 2007; 8:37.
12. Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003; 62: 870-4. (Pubitemid 37026499)
13. Kroot EJ, De Jong BA, Van Leeuwen MA et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000; 43:1831-5.
14. Solanki K, Spellerberg M, Chapman P, Moller P, O'Donnell J. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. N Z Med J 2004; 117: U1097.
15. Ordeig J, Guardia J. Diagnostic value of anti-keratin antibodies in rheumatoid arthritis. J Rheumatol 1984; 11: 602-4. (Pubitemid 15215044)
16. Meyer O, Combe B, Elias A et al. Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Ann Rheum Dis 1997; 56: 682-5. (Pubitemid 28007927)
17. Vasiliauskiene L, Wiik A, Hoier-Madsen M. Prevalence and clinical significance of anti-keratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60: 459-66. (Pubitemid 32417417)
18. Agrawal S, Misra R, Aggarwal A. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 2007; 26: 201-4. (Pubitemid 46020244)
19. Päi S, Päi L, Birkenfeldt R. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol 1998; 27: 252-6. (Pubitemid 28416980)
20. Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Rönnelid J. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 2007; 66: 59-64. (Pubitemid 46044861)
21. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumotology 2002; 41: 809-814. (Pubitemid 34822965)
22. Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti- CCP). Ann Rheum Dis 2004; 63: 1090-5. (Pubitemid 39120360)
23. Ronnelid J, Wick MC, Lampa J et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005; 64: 1744-9. (Pubitemid 41667149)
24. Teitsson I, Withrington RH, Seifert MH, Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis 1984; 43: 673-678.
25. Tarkowski A, Nilsson L A. Isotype specific measurement of rheumatoid factor with reference to clinical features of rheumatoidarthritis. J Clin Lab Immunol 1983; 12: 129-35. (Pubitemid 14245959)
26. Shankar S, Grover R, Handa R. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis. Indian J Med Res 2006; 124: 689-96. (Pubitemid 46592110)
27. Mewar D, Coote A, Moore DJ et al. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 2006; 8: R128.